FDA approval - McKnight's Long Term Care News

FDA approval

Clinical briefs for Monday, June 14

3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug … U.S. suspends COVID J&J vaccine shipments as backlog builds; extends expiration dates … VoiceFriend adds new discharged patient module for post-acute care … Computerized tests show how poorly fitting N95 masks increase risk of infection … FDA recalls unapproved COVID test that used falsified data … Parkinson’s drug candidates to be targeted to genetic groups in new Abbie biopharma collaboration

Clinical briefs for Wednesday, June 9

Twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug … Biden administration advises changes to policies linked to N95 shortages … Frailty tied to increased mortality in COVID: A living review and meta-analysis … In type 1 diabetes, blood sugar extremes are tied to sixfold risk of dementia … Exercise likely to be best treatment for depression in coronary heart disease … “Immunological memory” protects against COVID re-infection for at least 11 months, analysis shows

Next post in News